12:00 AM
Sep 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Arch Biopartners, University of Alberta deal

Arch acquired an option to license IP related to an undisclosed irritable bowel syndrome (IBS) diagnostic technology invented at...

Read the full 72 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >